Signaling Pathways
Signal transduction pathways constitute a precisely regulated network through which cells perceive external stimuli and initiate intracellular responses. Core research in this field focuses on the mechanisms of molecular signal transmission and regulation within cells and typically encompasses three fundamental stages: signal initiation, signal propagation through cascades, and downstream effector responses. Key molecules—including proteins, nucleic acids, and small molecules—interact with high specificity and are subject to tight regulation (e.g., protein phosphorylation, molecular activation/inhibition). These processes underpin the full spectrum of cellular activities, including proliferation, differentiation, metabolism, apoptosis, and immune responses. While accurate regulation of these pathways is essential for maintaining organismal homeostasis, their dysregulation is a major driver of the onset and progression of diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
APExBIO is strongly committed to advancing life science research by providing a comprehensive portfolio of small-molecule tools designed to support the elucidation of signaling mechanisms and the identification of key regulatory targets—critical steps for deciphering disease etiology and developing innovative therapies. Our offerings span all major signal transduction pathways, including classical pathways (e.g., PI3K/Akt, MAPK, NF-κB), emerging modalities (e.g., ferroptosis, cuproptosis, pyroptosis), and research on pathway crosstalk. With tens of thousands of products—including inhibitors, activators, and modulators—we robustly support research in oncology, immunology, neuroscience, epigenetics, and other key fields.
Every APExBIO product undergoes rigorous functional validation and purity testing, ensuring suitability for diverse research applications such as pathway mechanism studies, target identification and validation, drug activity evaluation, cell-based assays, and animal model development. We complement our high-quality tools with comprehensive support: each product is supplied with detailed chemical property reports, biological activity data, standardized usage guidelines, and extensive literature citations in high-impact journals. In addition, we provide end-to-end assistance—from product selection and experimental protocol optimization to technical troubleshooting—enabling researchers to rely on tool quality, focus on core scientific questions, and accelerate progress in signal transduction research and translational medicine.
-
BA1646 K6PC-5Summary: K6PC-5, a ceramide derivative, is a sphingosine kinase 1 activator that causes a transient and rapid increase in intracellular calcium levels. -
BA1647 DSHS00884Summary: Effective inhibitors. -
BA1649 EBOV-IN-1Summary: EBOV-IN-1 (com3.47) is an adamantane dipeptide piperazine that is an Ebola virus (EBOV) inhibitor. -
BA1650 AnsuvimabSummary: Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal antibody with antiviral activity against Zaire Ebola virus. -
BA1651 MaftivimabSummary: Maftivimab (REGN3470-3471-3479) is a lineage virus inhibitor and is a Food and Active Molecule Administration (FDA) approved agent. -
BA1652 ASN03576800Summary: ASN03576800 may be a potent inhibitor of Ebola virus matrix proteins during virus assembly and outgrowth. -
BA1654 BVDV-IN-1Summary: BVDV-IN-1 is a bovine viral diarrhea virus non-nucleoside inhibitor (NNI). -
BA1655 DB772Summary: DB772 is a bovine viral diarrhea virus inhibitor. -
BA1656 LabMol-319Summary: LabMol-319 is a potent Zika virus inhibitor. -
BA1657 OlorofimSummary: Olorofim (F901318) selectively inhibits fungal dihydroorotic acid dehydrogenase, a key enzyme in the pyrimidine biosynthetic pathway.

